Deals
Glaxo CFO Says Multibillion-Dollar M&A Not ‘on the Cards’
This article is for subscribers only.
GlaxoSmithKline PLC, the U.K.’s largest drugmaker, isn’t considering large-scale acquisitions, Chief Financial Officer Simon Dingemans said.
“Our emerging-markets business made a number of acquisitions two or three years ago,” Dingemans said in an interview today with Betty Liu on Bloomberg Television’s “In the Loop.” “We’re very comfortable with the footprint we have. If we do any M&A it’s going to be relatively small bolt-ons and in-fills.”